{
    "organizations": [],
    "uuid": "dfb3d206cd4745e4c4df34312137a59d7dd0f2c0",
    "author": "",
    "url": "https://www.reuters.com/article/brief-cardiome-announces-expanded-label/brief-cardiome-announces-expanded-label-for-aggrastat-in-china-idUSFWN1PI0TI",
    "ord_in_thread": 0,
    "title": "BRIEF-Cardiome Announces Expanded Label For Aggrastat In China",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 39 PM / Updated 11 minutes ago BRIEF-Cardiome Announces Expanded Label For Aggrastat In China Reuters Staff 1 Min Read \nJan 23 (Reuters) - Cardiome Pharma Corp: \n* CARDIOME ANNOUNCES EXPANDED LABEL FOR AGGRASTATÂ® IN CHINA INCLUDING NEW STEMI INDICATION AND HIGH DOSE BOLUS REGIMEN \n* CARDIOME PHARMA - AGGRASTAT EXPANDED LABEL NOW INCLUDE PATIENTS WITH STEMI WHO ARE INTENDED FOR PRIMARY PERCUTANEOUS CORONARY INTERVENTION \n* CARDIOME PHARMA - CHINESE CENTER FOR DRUG EVALUATION ALSO APPROVED AGGRASTAT HIGH DOSE BOLUS REGIMEN TO BE USED ON BOTH INDICATED PATIENT POPULATIONS IN STUDY Source text for Eikon: Further company coverage:",
    "published": "2018-01-23T15:38:00.000+02:00",
    "crawled": "2018-01-23T16:00:05.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "announces",
        "expanded",
        "label",
        "aggrastat",
        "china",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "cardiome",
        "pharma",
        "corp",
        "cardiome",
        "announces",
        "expanded",
        "label",
        "china",
        "including",
        "new",
        "stemi",
        "indication",
        "high",
        "dose",
        "bolus",
        "regimen",
        "cardiome",
        "pharma",
        "aggrastat",
        "expanded",
        "label",
        "include",
        "patient",
        "stemi",
        "intended",
        "primary",
        "percutaneous",
        "coronary",
        "intervention",
        "cardiome",
        "pharma",
        "chinese",
        "center",
        "drug",
        "evaluation",
        "also",
        "approved",
        "aggrastat",
        "high",
        "dose",
        "bolus",
        "regimen",
        "used",
        "indicated",
        "patient",
        "population",
        "study",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}